
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Dynein IC1, cytosolic CRISPR/Cas9 KO Plasmid (h) | sc-405213 | 20 µg | $397.00 | |||
Dynein IC1, cytosolic HDR Plasmid (h) | sc-405213-HDR | 20 µg | $445.00 |
DYNC1I1 encodes the cytosolic dynein intermediate chain 1, a core subunit of the minus-end–directed dynein motor complex that drives microtubule-based transport. Dynein IC1 supports cargo binding and coordination of dynein–dynactin interactions, enabling retrograde trafficking of vesicles and organelles, centrosome positioning, and mitotic spindle organization. Through these roles, DYNC1I1 contributes to pathways governing endosomal-lysosomal transport, Golgi organization, and cell cycle progression. Dysregulation of cytoplasmic dynein subunits has been linked to defects in neuronal transport and chromosome segregation, making DYNC1I1 a useful target for studying mechanisms of neurodegeneration and genome instability in cellular models.
Dynein IC1, cytosolic CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the DYNC1I1 gene in human cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the DYNC1I1 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, Dynein IC1, cytosolic HDR Plasmid (h) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined DYNC1I1 target site.
When co-transfected with Dynein IC1, cytosolic CRISPR/Cas9 KO Plasmid (h):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the DYNC1I1 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.